[1] Id Boufker H, Lagneaux L, Najar M, et al. The Src inhibitor dasatinib accelerates the differentiation of human bone marrow-derived mesenchymal stromal cells into osteoblasts. BMC Cancer. 2010;10:298.
[2] Griffin MD, Ryan AE, Alagesan S, et al. Anti-donor immune responses elicited by allogeneic mesenchymal stem cells: what have we learned so far. Immunol Cell Biol. 2013;91(1): 40-51.
[3] Stagg J, Galipeau J. Immune plasticity of bone marrow-derived mesenchymal stromal cells. Handb Exp Pharmacol. 2007;(180):45-66.
[4] Stagg J. Immune regulation by mesenchymal stem cells: two sides to the coin. Tissue Antigens. 2007;69(1):1-9.
[5] Griffin MD, Ritter T, Mahon BP. Immunological aspects of allogeneic mesenchymal stem cell therapies. Hum Gene Ther. 2010;21(12):1641-1655.
[6] Jorgensen C, Djouad F, Apparailly F, et al. Engineering mesenchymal stem cells for immunotherapy. Gene Ther. 2003;10(10):928-931.
[7] Kalbasi Anaraki P, Patecki M, Larmann J, et al. Urokinase receptor mediates osteogenic differentiation of mesenchymal stem cells and vascular calcification via the complement C5a receptor. Stem Cells Dev. 2014;23(4):352-362.
[8] 张晨,王坤正,强辉,等.兔骨髓基质干细胞的体外培养及生物学活性研究[J].西安交通大学学报,2010,31(2):138-142.
[9] Mödder UI, Khosla S. Skeletal stem/osteoprogenitor cells: current concepts, alternate hypotheses, and relationship to the bone remodeling compartment. J Cell Biochem. 2008; 103(2):393-400.
[10] Tan SL, Ahmad TS, Selvaratnam L, et al. Isolation, characterization and the multi-lineage differentiation potential of rabbit bone marrow-derived mesenchymal stem cells. J Anat. 2013;222(4):437-450.
[11] Sanchez-Ramos J, Song S, Cardozo-Pelaez F, et al. Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol. 2000;164(2):247-256.
[12] 孙健,余优成,顾章愉,等. BMP-2对大鼠骨髓间充质干细胞成骨作用的影响[J].上海口腔医学,2011,20(4): 352-357.
[13] Liu H, Peng H, Wu Y, et al. The promotion of bone regeneration by nanofibrous hydroxyapatite/chitosan scaffolds by effects on integrin-BMP/Smad signaling pathway in BMSCs. Biomaterials. 2013;34(18):4404-4417.
[14] Fang H, Yang X, Chen A, et al. Effect of rhBMP-2 and osteogenic revulsants on proliferation and differentiation of bone marrow stromal cells in rats. J Huazhong Univ Sci Technolog Med Sci. 2007;27(5):561-563.
[15] Tang KC, Trzaska KA, Smirnov SV, et al. Down-regulation of MHC II in mesenchymal stem cells at high IFN-gamma can be partly explained by cytoplasmic retention of CIITA J Immunol. 2008;180(3):1826-1833.
[16] Bartholomew A, Stugeon C, Nelson M, et al. Allogeneic mesenchymal stem cells, hane significant immunosuppressive activity. Exp Hematol. 1999;27:123-139.
[17] Tse WT, Pendleton JD, Beyer WM, et al. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation. 2003;75(3): 389-397.
[18] Ankrum JA, Ong JF, Karp JM. Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol. 2014;32(3):252-260. |